← brief for 2026-11-12 · People & money
Application of GLP-1 receptor agonists in kidney disease: a bibliometric analysis
Key takeaways
This paper maps the research landscape for GLP-1 drugs in kidney disease. It looks at how scientists are collaborating and where the field is heading. It is a review of existing studies, not a new clinical trial, so it reports no new patient results.
Who did this work
钱梦君 (Heilongjiang University of Chinese Medicine) · Danmai Zhao (Heilongjiang University of Chinese Medicine) · Jiawei Dai (Heilongjiang University of Chinese Medicine) · Yiyang Yu (Heilongjiang University of Chinese Medicine) · Rui Zhang (First Affiliated Hospital of Heilongjiang University of Chinese Medicine) · Zhong-qiu Luan (First Affiliated Hospital of Heilongjiang University of Chinese Medicine)
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-11
https://doi.org/10.3389/fmed.2026.1952453